AstraZeneca to Acquire EsoBiotec in $1 Billion Deal to Expand In Vivo Cell Therapy Portfolio
AstraZeneca, a global biopharmaceutical leader, has announced a definitive agreement to acquire EsoBiotec, a Belgium-based biotechnology company specializing in in […]
